Generic Name and Formulations:
Oxybutynin chloride 10% (1g/sachet); topical gel; contains alcohol.
Indications for GELNIQUE:
Overactive bladder (OAB) with urge urinary incontinence, urgency, and frequency.
Apply 1g gel (one sachet) once daily to dry, intact skin on abdomen, upper arm/shoulders, or thighs. Rotate application sites; avoid use of same site on consecutive days. Wash hands after application. Avoid washing area/showering for 1hr after application.
Urinary or gastric retention. Uncontrolled narrow angle glaucoma.
Bladder outflow obstruction. GI obstruction. Decreased GI motility. Ulcerative colitis. Intestinal antony. Gastroesophageal reflux. Esophagitis. Controlled narrow angle glaucoma. Discontinue if skin hypersensitivity or angioedema develops. Monitor for anticholinergic CNS effects; consider discontinuing if occur. Avoid in myasthenia gravis; discontinue if symptoms occur. Hepatic or renal dysfunction. Minimize skin transference: cover application site with clothing if direct contact is anticipated. Exposure to high environmental temperatures. Gel is flammable. Pregnancy. Nursing mothers.
Caution with drugs that can cause or exacerbate esophagitis (eg, bisphosphonates). Additive effects with other anticholinergics.
Dry mouth, application site reactions (eg, pruritus, dermatitis, papules, erythema), urinary tract infection, dizziness, nasopharyngitis, fatigue, headache, constipation, other anticholinergic effects (eg, CNS).
Sign Up for Free e-newsletters
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- The Caregivers' Cancer Journey
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Fertility Preservation in Hodgkin's Lymphoma Patients That Undergo Targeted Molecular Therapies: An Important Step Forward From the Chemotherapy Era
- Survey of ACEP Councilors Reveals NP, PA Staffing Models, Practice Patterns Vary
- Breath Analysis May Be an Effective Diagnostic for Pancreatic Cancer
- Genetic Susceptibility to Pancreatic Cancer Linked to 6 Specific Gene Mutations
- Dinner Hour and Sleep Habits Affect Risk of Breast, Prostate Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|